Goldman Sachs’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$243M Buy
2,762,770
+1,602,598
+138% +$141M 0.03% 433
2025
Q1
$106M Sell
1,160,172
-1,131,549
-49% -$103M 0.02% 656
2024
Q4
$198M Buy
2,291,721
+194,720
+9% +$16.8M 0.03% 427
2024
Q3
$199M Buy
2,097,001
+650,000
+45% +$61.8M 0.03% 446
2024
Q2
$132M Buy
1,447,001
+100,000
+7% +$9.15M 0.02% 577
2024
Q1
$122M Sell
1,347,001
-49,999
-4% -$4.53M 0.02% 587
2023
Q4
$114M Sell
1,397,000
-250,971
-15% -$20.4M 0.02% 616
2023
Q3
$132M Buy
1,647,971
+532,285
+48% +$42.5M 0.03% 508
2023
Q2
$87.9M Sell
1,115,686
-484,213
-30% -$38.1M 0.02% 672
2023
Q1
$124M Sell
1,599,899
-252,488
-14% -$19.6M 0.03% 522
2022
Q4
$144M Sell
1,852,387
-249,870
-12% -$19.4M 0.04% 469
2022
Q3
$141M Buy
2,102,257
+1,742,570
+484% +$117M 0.04% 461
2022
Q2
$27.6M Buy
359,687
+212,560
+144% +$16.3M 0.01% 1386
2022
Q1
$11.7M Sell
147,127
-209
-0.1% -$16.7K ﹤0.01% 2107
2021
Q4
$11.3M Buy
147,336
+209
+0.1% +$16.1K ﹤0.01% 2174
2021
Q3
$10.7M Hold
147,127
﹤0.01% 2208
2021
Q2
$10.7M Sell
147,127
-1,300,000
-90% -$95M ﹤0.01% 2200
2021
Q1
$99.9M Buy
1,447,127
+1,227,000
+557% +$84.7M 0.03% 582
2020
Q4
$14.6M Hold
220,127
﹤0.01% 1795
2020
Q3
$13.7M Sell
220,127
-44,373
-17% -$2.76M ﹤0.01% 1740
2020
Q2
$16.5M Hold
264,500
0.01% 1594
2020
Q1
$14.4M Sell
264,500
-79,500
-23% -$4.32M 0.01% 1547
2019
Q4
$22.1M Sell
344,000
-20,000
-5% -$1.28M 0.01% 1543
2019
Q3
$20.7M Buy
364,000
+200,000
+122% +$11.4M 0.01% 1496
2019
Q2
$9.62M Sell
164,000
-286,000
-64% -$16.8M ﹤0.01% 1965
2019
Q1
$27.3M Sell
450,000
-250,012
-36% -$15.2M 0.01% 1402
2018
Q4
$38.4M Sell
700,012
-100,116
-13% -$5.49M 0.01% 1123
2018
Q3
$51.5M Sell
800,128
-8,961
-1% -$577K 0.01% 1070
2018
Q2
$47.7M Buy
809,089
+158,363
+24% +$9.34M 0.01% 1105
2018
Q1
$37M Buy
650,726
+400,591
+160% +$22.8M 0.01% 1216
2017
Q4
$14.8M Sell
250,135
-100,800
-29% -$5.98M ﹤0.01% 1713
2017
Q3
$20.3M Buy
350,935
+873
+0.2% +$50.4K 0.01% 1572
2017
Q2
$20.7M Sell
350,062
-400,000
-53% -$23.6M 0.01% 1539
2017
Q1
$41.4M Buy
750,062
+200,000
+36% +$11M 0.01% 1113
2016
Q4
$28.9M Sell
550,062
-1,250,046
-69% -$65.6M 0.01% 1299
2016
Q3
$103M Buy
1,800,108
+285,246
+19% +$16.4M 0.03% 582
2016
Q2
$88.8M Sell
1,514,862
-4,942
-0.3% -$290K 0.03% 615
2016
Q1
$87.4M Buy
1,519,804
+14,796
+1% +$851K 0.03% 624
2015
Q4
$98.3M Buy
1,505,008
+359,211
+31% +$23.5M 0.03% 547
2015
Q3
$72.2M Buy
1,145,797
+852
+0.1% +$53.7K 0.02% 621
2015
Q2
$81M Buy
1,144,945
+692,032
+153% +$49M 0.03% 620
2015
Q1
$31.8M Buy
452,913
+87,754
+24% +$6.16M 0.01% 1102
2014
Q4
$23.5M Sell
365,159
-292,029
-44% -$18.8M 0.01% 1229
2014
Q3
$41.8M Buy
657,188
+402,648
+158% +$25.6M 0.01% 887
2014
Q2
$15.8M Buy
254,540
+200,900
+375% +$12.5M ﹤0.01% 1388
2014
Q1
$3.13M Sell
53,640
-11,610
-18% -$678K ﹤0.01% 2296
2013
Q4
$3.47M Buy
65,250
+100
+0.2% +$5.31K ﹤0.01% 2259
2013
Q3
$3.12M Sell
65,150
-1,301
-2% -$62.2K ﹤0.01% 2221
2013
Q2
$3.02M Buy
+66,451
New +$3.02M ﹤0.01% 2090